Arcadia Biosciences RKDA
NASDAQ RKDA
$0.48 +0.01 (+2.04%)
As of: Sep 9, 2026 · 3:59 PM EDT

Arcadia Biosciences (RKDA) Equity Income (2014)

Arcadia Biosciences' (RKDA) quarterly Equity Income came in at -$536000.0 in Q2 2014, down 35.35% quarter-over-quarter from -$396000.0 in Q1 2014.

Analysis

Arcadia Biosciences (RKDA) Equity Income (2014) Analysis & Trends

Arcadia Biosciences (RKDA) has reported Equity Income for 1 consecutive years, with -$536000.0 the latest figure, recorded in Q2 2014.

  • For the quarter ending Q2 2014, Equity Income changed N/A year-over-year to -$536000.0; the trailing twelve-month figure through Dec 2014 stood at -$932000.0 (changed N/A YoY), and the FY2014 full-year result was -$932000.0, changed N/A from the prior year.
  • Equity Income declined to -$536000.0 in Q2 2014 per RKDA's latest filing, from -$396000.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$396000.0 in Q1 2014 and bottomed at -$536000.0 in Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Coca Cola 376.77 Bn 362.62 Bn 8.42 Bn 604.00 Mn
2 Pepsico 186.88 Bn 176.17 Bn 13.11 Bn -
3 Monster Beverage 83.76 Bn 80.34 Bn 1.42 Bn -
4 Keurig Dr Pepper 43.72 Bn 42.21 Bn 3.07 Bn -
5 Andina Bottling 23.05 Bn -348.36 Bn 698.26 Mn 1.83 Bn
6 Coca Cola Femsa Sab De Cv 18.74 Bn 17.96 Bn 2.06 Bn -
7 Coca-Cola Consolidated 12.59 Bn 12.42 Bn 778.41 Mn -
8 Primo Brands 7.62 Bn 7.25 Bn 548.70 Mn -
9 Celsius Holdings 7.05 Bn 6.42 Bn 393.69 Mn -
10 Arcadia Biosciences 1.39 Mn -2.81 Mn 631,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -536,000.00
Mar 31, 2014 -396,000.00